{
    "id": "35bc3a6f-a5a4-4253-e063-6394a90ad77c",
    "indications": "glipizide metformin hydrochloride tablets usp indicated adjunct diet exercise improve glycemic control adults type 2 diabetes mellitus .",
    "warningsAndPrecautions": "glipizide metformin hydrochloride tablets , usp available follows : 5 mg/500 mg pink , film-coated , modified capsule-shaped tablets , debossed “ 93 ” one side “ 7457 ” ndc : 70518-0373-00 ndc : 70518-0373-01 packaging : 90 1 bottle plastic packaging : 180 1 bottle plastic storage store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp , child-resistant closure ( required ) . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "glipizide metformin hydrochloride tablets contraindicated patients : severe renal impairment ( egfr 30 ml/min/1.73 2 ) ( ) . known hypersensitivity glipizide metformin hydrochloride . acute chronic metabolic acidosis , including diabetic ketoacidosis , without coma . diabetic ketoacidosis treated insulin .",
    "ingredients": [
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "POLYETHYLENE GLYCOL 4000",
            "code": "4R4HFI6D95"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "POVIDONE K90",
            "code": "RDH86HJV5Z"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "GLIPIZIDE",
            "code": "X7WDT95N5C"
        },
        {
            "name": "METFORMIN HYDROCHLORIDE",
            "code": "786Z46389E"
        }
    ],
    "organization": "REMEDYREPACK INC.",
    "name": "Glipizide and Metformin Hydrochloride",
    "effectiveTime": "20250522",
    "indications_original": "Glipizide and metformin hydrochloride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
    "warningsAndPrecautions_original": "Glipizide and metformin hydrochloride tablets, USP are available as follows:\n                  5 mg/500 mg are pink, film-coated, modified capsule-shaped tablets, debossed with “93” on one side and “7457” on the other in\n                  NDC: 70518-0373-00\n                  NDC: 70518-0373-01\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 180 in 1 BOTTLE PLASTIC\n                  \n                  STORAGE\n                  Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Glipizide and metformin hydrochloride tablets are contraindicated in patients with:\n                  \n                     Severe renal impairment (eGFR below 30 mL/min/1.73 m\n        \n  \n   2) (see \n        \n  \n   WARNINGS and \n        \n  \n   PRECAUTIONS).\n       \n \n  \n                     Known hypersensitivity to glipizide or metformin hydrochloride.\n                     Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Diabetic ketoacidosis should be treated with insulin."
}